Segregating the effects of ferric citrate‐mediated iron utilization and FGF23 in a mouse model of CKD
Abstract Ferric citrate (FC) is an approved therapy for chronic kidney disease (CKD) patients as a phosphate (Pi) binder for dialysis‐dependent CKD, and for iron deficiency anemia (IDA) in non‐dialysis CKD. Elevated Pi and IDA both lead to increased FGF23, however, the roles of iron and FGF23 during...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wiley
2022-06-01
|
| Schriftenreihe: | Physiological Reports |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.14814/phy2.15307 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|